Hospira (HSP -9.1%) shares plunge after RBC Capital says the generic injectable drug maker may...

|By:, SA News Editor

Hospira (HSP -9.1%) shares plunge after RBC Capital says the generic injectable drug maker may face “widespread” production breakdowns that could take two to three years to correct. Hospira has been working to correct flaws that led to recalls of two drugs in 2009 and 2010, but RBC believes the company’s manufacturing issues are "far greater than investors realize."